251 related articles for article (PubMed ID: 19951202)
1. Imipenem resistance in Pseudomonas aeruginosa: emergence, epidemiology, and impact on clinical and economic outcomes.
Lautenbach E; Synnestvedt M; Weiner MG; Bilker WB; Vo L; Schein J; Kim M
Infect Control Hosp Epidemiol; 2010 Jan; 31(1):47-53. PubMed ID: 19951202
[TBL] [Abstract][Full Text] [Related]
2. Imipenem resistance among pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes.
Lautenbach E; Weiner MG; Nachamkin I; Bilker WB; Sheridan A; Fishman NO
Infect Control Hosp Epidemiol; 2006 Sep; 27(9):893-900. PubMed ID: 16941312
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and impact of imipenem resistance in Acinetobacter baumannii.
Lautenbach E; Synnestvedt M; Weiner MG; Bilker WB; Vo L; Schein J; Kim M
Infect Control Hosp Epidemiol; 2009 Dec; 30(12):1186-92. PubMed ID: 19860563
[TBL] [Abstract][Full Text] [Related]
4. Imipenem-resistant Pseudomonas aeruginosa infection at a medical-surgical intensive care unit: risk factors and mortality.
Furtado GH; Bergamasco MD; Menezes FG; Marques D; Silva A; Perdiz LB; Wey SB; Medeiros EA
J Crit Care; 2009 Dec; 24(4):625.e9-14. PubMed ID: 19592213
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for recovery of imipenem- or ceftazidime-resistant pseudomonas aeruginosa among patients admitted to a teaching hospital in Brazil.
Fortaleza CM; Freire MP; Filho Dde C; de Carvalho Ramos M
Infect Control Hosp Epidemiol; 2006 Sep; 27(9):901-6. PubMed ID: 16941313
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients.
Zavascki AP; Cruz RP; Goldani LZ
J Hosp Infect; 2005 Feb; 59(2):96-101. PubMed ID: 15620442
[TBL] [Abstract][Full Text] [Related]
7. The risk factors for acquisition of imipenem-resistant Pseudomonas aeruginosa in the burn unit.
Ozkurt Z; Ertek M; Erol S; Altoparlak U; Akcay MN
Burns; 2005 Nov; 31(7):870-3. PubMed ID: 15975720
[TBL] [Abstract][Full Text] [Related]
8. Imipenem-resistant Pseudomonas aeruginosa gastrointestinal carriage among hospitalized patients: risk factors and resistance mechanisms.
Lepelletier D; Cady A; Caroff N; Marraillac J; Reynaud A; Lucet JC; Corvec S
Diagn Microbiol Infect Dis; 2010 Jan; 66(1):1-6. PubMed ID: 19775845
[TBL] [Abstract][Full Text] [Related]
9. Imipenem-resistant Pseudomonas aeruginosa: risk factors for nosocomial infections.
Onguru P; Erbay A; Bodur H; Baran G; Akinci E; Balaban N; Cevik MA
J Korean Med Sci; 2008 Dec; 23(6):982-7. PubMed ID: 19119440
[TBL] [Abstract][Full Text] [Related]
10. Clinical surveillance of surgical imipenem-resistant Pseudomonas aeruginosa infection in a Japanese hospital.
Sasaki M; Hiyama E; Takesue Y; Kodaira M; Sueda T; Yokoyama T
J Hosp Infect; 2004 Feb; 56(2):111-8. PubMed ID: 15019222
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients.
Harris AD; Smith D; Johnson JA; Bradham DD; Roghmann MC
Clin Infect Dis; 2002 Feb; 34(3):340-5. PubMed ID: 11774081
[TBL] [Abstract][Full Text] [Related]
12. [A case-control study on the risk factors of nosocomial infection caused by imipenem-resistant Pseudomonas aeruginosa].
Peng SH; Jin ZJ; Luo L; Li CR
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jul; 26(7):511-4. PubMed ID: 16335003
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for and impact of infection or colonization with aztreonam-resistant Pseudomonas aeruginosa.
Gasink LB; Fishman NO; Nachamkin I; Bilker WB; Lautenbach E
Infect Control Hosp Epidemiol; 2007 Oct; 28(10):1175-80. PubMed ID: 17828695
[TBL] [Abstract][Full Text] [Related]
14. Fluoroquinolone-resistant Pseudomonas aeruginosa: assessment of risk factors and clinical impact.
Gasink LB; Fishman NO; Weiner MG; Nachamkin I; Bilker WB; Lautenbach E
Am J Med; 2006 Jun; 119(6):526.e19-25. PubMed ID: 16750968
[TBL] [Abstract][Full Text] [Related]
15. Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients.
Peña C; Guzmán A; Suarez C; Dominguez MA; Tubau F; Pujol M; Gudiol F; Ariza J
Antimicrob Agents Chemother; 2007 Jun; 51(6):1967-71. PubMed ID: 17420207
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia: clinical impact of antimicrobial resistance on outcome.
Joo EJ; Kang CI; Ha YE; Kang SJ; Park SY; Chung DR; Peck KR; Lee NY; Song JH
Microb Drug Resist; 2011 Jun; 17(2):305-12. PubMed ID: 21381966
[TBL] [Abstract][Full Text] [Related]
17. Controlling the clonal spread of Pseudomonas aeruginosa infection.
Pereira GH; Levin AS; Oliveira HB; Moretti ML
Infect Control Hosp Epidemiol; 2008 Jun; 29(6):549-52. PubMed ID: 18476775
[TBL] [Abstract][Full Text] [Related]
18. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa.
Marra AR; Bar K; Bearman GM; Wenzel RP; Edmond MB
J Infect; 2006 Jul; 53(1):30-5. PubMed ID: 16253333
[TBL] [Abstract][Full Text] [Related]
19. ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France.
Diene SM; L'homme T; Bellulo S; Stremler N; Dubus JC; Mely L; Leroy S; Degand N; Rolain JM
Int J Antimicrob Agents; 2013 Sep; 42(3):268-71. PubMed ID: 23880169
[TBL] [Abstract][Full Text] [Related]
20. Carbapenem-resistant Pseudomonas aeruginosa in Taiwan: Prevalence, risk factors, and impact on outcome of infections.
Lin KY; Lauderdale TL; Wang JT; Chang SC
J Microbiol Immunol Infect; 2016 Feb; 49(1):52-9. PubMed ID: 24662016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
